"Masked" Cancer Drug Activates Once It Reaches the Tumor To Reduce Side Effects - Technology Networks

Researchers have long suspected that interleukin-12 could be a powerful cancer treatment, but it can cause unwanted adverse effects. Now, researchers have developed a version of the molecule that remains inactive until it reaches the tumor site.

Many cancer treatments are notoriously savage on the body; they attack healthy cells at the same time as tumor cells, causing a plethora of side effects. Now, researchers at the University of Chicago… [+4056 chars]

full article...